Province/ Territory |
DTaP-IPV-Hib | DTaP-IPV | Td, Tdap or Td-IPV |
HB | MMR | Var | Men-C | Menactra-(Groups A, C, Y, W-135 conjugate) | Pneu-C-7 | Inf | HPV |
NACI recom- mendation |
2,4,6,18 mths | 4-6 yrs | 14-16 yrs | Infancy (3 doses) OR Pre-teen/teen |
12 mths, 18m/4-6 yrs | Children between 12 & 18 mths | 2, 4, 6 mths OR 12 mths, if not yet given OR 14-16 yrs, if not yet given |
High risk individuals 2-55 yrs of age2 | 2, 4, 6, 12/15 mths | 6-23 mths (1-2 doses) | Females 9-26 yrs (3 doses at 0, 2 and 6 months)1 |
BC | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 | 2,4,6 mths Gr 6 Catch- up (2 doses) | 12, 18 mths | 12 mths, 4-6 yr olds, and Grade 6 |
2,12 mths Gr 6 catch-up |
Healthy children: 2,4,12 mths High risk children: 2,4,6,12 mths |
6-23 mths | Starting in Sept 2008: Females in Gr 6 and Gr.9 (3 doses given @ 0, 2, 6 mos) |
|
AB | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 | Gr. 5 | 12 mths, 4-6 yrs | 12 mths | 2, 4 and 12 months | 2,4,6,18 mths | 6-59 mths | Starting in Sept 2008: Females in Gr 5. Gr 9 girls from 2009 to 2012 | |
SK | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 8 | Gr. 6 | 12, 18 mths and Gr 8 & 12 catch up | 12 mths Gr 6 catch-up |
12 mths 4-6 yr and Gr 6 catch up |
2,4,6,18 mths At risk children up to 59 mths |
6-23 mths | Starting in Sept 2008: Gr 6 (3 doses @ 0,2 and 6mos) and Females in Gr 7 for one year only |
|
MB | 2,4,6,18 mths | 4-6 yrs | dTap, 14-16 yrs | Gr. 4 | 12 mths, 4-6 yrs | 12 mths 4-6 yr old catch-up, Gr 4 catch-up |
Gr. 4 * will be changing to 12 month of age in Jan 2009 |
2,4,6,18 mths | 6-23 mths | Starting in Sept 2008: Females in Gr 6. |
|
ON | 2,4,6,18 mths | 4-6 yrs | dTap 14-16 yrs | Gr. 7 (2 doses) | 12, 18 mths | 15 mths | 12 mths, Gr. 7 catch up and 15-19 yr catch up | 2,4,6,15 mths | ≥6 mths | Females in Gr 8 (3 doses @ months 0, 2, and 6) | |
QC | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 10 and 1 dose for ≥ 7 yrs | Gr. 4 | 12, 18 mths | 12 mths 4-6 yr old catch-up, Gr 4 catch up, health professional non-immune |
12 mths | 2,4,12 mths | 6-23 mths | Starting in Sept 2008 Grade 4 and Secondary 3rd of high school | |
NB | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 Gr 6 catch up (2006-2009) |
0, 2, 6 mths | 12, 18 mths | 12 mths | 12 mths |
Gr 9 | 2,4,6,18 mths | 6-23 mths | Begins Sept 2008 for girls in Gr 7 & 8 |
NS | 2,4,6,18 mths | 4-6 yrs | dTap, 14-16 yrs, Gr 7 | Program on hold until 2010 | 12 mths, 4-6 yrs. | 12 mths 1-6 yr old catch-up |
12 mths , Gr 7 and 14-16 yr old catch-up |
2,4,6,18 mths | 6-23 mths | Females in Gr 7 | |
PE | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 | 2,4,15 mths | 15, 18 mths | 12 mths | 12 mths | Gr 9 | 2,4,6,18 mths | Females in Grade 6 (3 doses @ 0,1-2 and 6 mths) | |
NL | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 | Gr. 4 | 12, 18 mths | 12 mths 4-6 yr old catch-up |
12 mths Gr 4 catch-up abd Gr 9 catch-up |
Used in outbreak situations | 2,4,6,18 mths | 6-23 mths | Females in Gr 6 (3 doses) and starting in Sept 2008, females in Gr 9 |
NT | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 | 0, 1, 6 mths | 12, 18 mths, Post secondary students attending schools outside NT | 12 mths Catch-up for children <5 yrs old | 2 and 12 mos catch-up for children < 5 yrs old and catch-up grade 9 |
Post secondary students attending schools outside NT | 2,4,6, 18 mths | 6-23 mths | |
YT | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 . | 2,4,12 mths, and ≤19 yrs if not previously immunized | 12, 18 mths | 12 mths | 2, 6 mths, grade 9 catch-up; post secondary students leaving school and/or not previously vaccinated. | 2,4,6,18 mths | 6-23 mths | Starting in March 2009, 3 doses for females in Gr 5 . For 2009 only, Gr 6 & 7 | |
NU | 2,4,6,18 mths | 4-6 yrs | dTap, Gr 9 | 0, 1, 9 mths | 12, 18 mths, Gr 12 | 15 mths | 12 mths 14-16 yr old catch-up |
2,4,6,15 mths | ≥6 mths | ||
Original Source: Canadian Nursing Coalition on Immunization, 2004 Updated: 2008-05-13 |
|||||||||||
Legend: DTaP: Diphtheria, Tetanus, Acellular Pertussis HB: Hepatitis B Hib: Haemophilus Influenzae Tybe b HPV: Human Papillomavirus Inf: Influenza IPV: Inactivated Polio Men C: Meningococcal conjugate MMR: Measles, Mumps, Rubella Pneu-C-7: Pneumococcal conjugate Var: Varicella |
|||||||||||
1 Recommended use: i) The HPV vaccine is recommended for females between 9 and 13 years of age, as this is before the onset of sexual intercourse for most females in Canada, and the efficacy would be greatest. ii) Females between the ages of 14 and 26 years would benefit from the HPV vaccine, even if they are already sexually active, as they may not yet have HPV infection and are very unlikely to have been infected with all four HPV types in the vaccine. iii) Females between the ages of 14 and 26 years who have had previous Pap abnormalities, including cervical cancer, or have had genital warts or known HPV infection would still benefit from the HPV vaccine.2 Specific recommendations for Menactra use can be found here: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-03/index_e.html |